|
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
|
3 Months Ended | |
|---|---|---|
|
Nov. 30, 2014
|
Nov. 30, 2013
|
|
| Expenses | ||
| Accounting and audit | $ 34,000us-gaap_ProfessionalFees | $ 0us-gaap_ProfessionalFees |
| Insurance | 1,518us-gaap_GeneralInsuranceExpense | 1,794us-gaap_GeneralInsuranceExpense |
| Advertising and promotions | 47,111us-gaap_MarketingAndAdvertisingExpense | 2,256us-gaap_MarketingAndAdvertisingExpense |
| Bank charges and exchange (gain)loss | (11,488)lxrp_BankChargesAndExchangeLoss | (12,890)lxrp_BankChargesAndExchangeLoss |
| Consulting | 155,603us-gaap_GeneralContractorCosts | 46,171us-gaap_GeneralContractorCosts |
| Fees and Dues | 11,647lxrp_FeesAndDues | 8,491lxrp_FeesAndDues |
| Interest expense from loan payable | 31,544us-gaap_InterestExpense | 58,625us-gaap_InterestExpense |
| Legal and professional | 24,364us-gaap_LegalFees | 280us-gaap_LegalFees |
| Office and miscellaneous | 5,624us-gaap_GeneralAndAdministrativeExpense | 112us-gaap_GeneralAndAdministrativeExpense |
| Research and Development | 48,040us-gaap_ResearchAndDevelopmentExpense | 0us-gaap_ResearchAndDevelopmentExpense |
| Rent | 28,106us-gaap_LeaseAndRentalExpense | 10,657us-gaap_LeaseAndRentalExpense |
| Telephone | 1,342us-gaap_DirectCommunicationsAndUtilitiesCosts | 1,796us-gaap_DirectCommunicationsAndUtilitiesCosts |
| Travel | 5,662us-gaap_TravelAndEntertainmentExpense | 5,178us-gaap_TravelAndEntertainmentExpense |
| Medical Marijuana Investment expense | 15,000lxrp_MedicalMarijuanaLicenseApplication | 19,293lxrp_MedicalMarijuanaLicenseApplication |
| Total operating expenses | 398,073us-gaap_OperatingExpenses | 141,763us-gaap_OperatingExpenses |
| (Loss) from continuing operations | (398,073)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | (141,763)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
| Income (Loss) from discontinued operations | 48,918us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax | 66,295us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax |
| Net (loss) for the period | (349,155)us-gaap_ComprehensiveIncomeNetOfTax | (75,468)us-gaap_ComprehensiveIncomeNetOfTax |
| Net (loss) attributable to: | ||
| Common shareholders | (347,249)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic | (75,468)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic |
| Non-controlling interests | $ (1,906)us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | $ 0us-gaap_NetIncomeLossAttributableToNoncontrollingInterest |
| Basic and diluted (loss) per share | $ (0.01)us-gaap_EarningsPerShareBasicAndDiluted | $ 0.00us-gaap_EarningsPerShareBasicAndDiluted |
| Weighted average number of common shares outstanding | ||
| - Basic and diluted | 23,369,040us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted | 16,431,452us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted |
| X | ||||||||||
|
- Definition
Bank charges and exchange loss No definition available.
|
| X | ||||||||||
|
- Definition
Fees and Dues No definition available.
|
| X | ||||||||||
|
- Definition
Medical marijuana license application No definition available.
|
| X | ||||||||||
|
- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs of direct communications and utilities incurred during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs related to general contracting services. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of income (loss) from a disposal group, net of income tax before extraordinary items allocable to noncontrolling interests. Includes, net of tax, income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. No definition available.
|
| X | ||||||||||
|
- Definition
The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Expenses incurred for travel and entertainment during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
|
- Details
|